HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HBW Market Executive Decisions: C&D, Bridges Consumer, DSM Nutrition, CRN Board Chair

Executive Summary

Bruno at Church & Dwight international helm; Chattem executives Long, Ramey launch Bridges Consumer; Atrium’s Ritz starts as CRN chairman; and DSM Nutritional Products chief Goppelsroeder leaving.

You may also be interested in...



With ‘Significant Headroom For Growth,' Is Standalone Space Ahead For DSM Nutrition?

DSM says its nutrition segment, which includes human and animal nutrition and personal care, has a “unique business model combining 'global products' and 'local solutions'” and showed 6% organic sales growth for 2020 and 8% for Q4.

Bridges Consumer Startup Reaches Brands For Specialty Conditions In Clarion Deal

Acquiring Clarion Brands from Swander Pace, Bridges Consumer Healthcare adds portfolio of OTC and supplement brands for symptoms including tinnitus, urinary pain relief and excessive sweating.

Wellness Market News: Nuritas-Pharmavite Peptides, Abbott Nutriton, Brain Armor, Trade Group Notes

Pharmavite tests bioactive peptides with Nuritas' AI platform; NPA questions FDA proposal to share data collected from US firms; NFL great Randy White promotes Brain Armor supplements; Abbott Nutrition sales up 4.4% for 2018; ONHA targets expanding omega-3 testing among consumers; CRN's Mister, Sidley's Bass co-chair regulatory conference; and 'Hero for the Planet' Plotkin speaks at AHPA meeting.

Related Content

Topics

UsernamePublicRestriction

Register

RS150966

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel